RGD-modified PEGylated paclitaxel nanocrystals with enhanced stability and tumor-targeting capability
Zhigang Huang(University of Shanghai for Science and Technology), Weiyue Lu(Fudan University), Jun Wang(University of Shanghai for Science and Technology), Zhepeng Liu(University of Shanghai for Science and Technology), Feng-mei Lv(University of Shanghai for Science and Technology), Shui-juan Cao(Fudan University), Yu Liu(Shanghai Medical College of Fudan University)
Cited by 71
Related Papers
Cyclic RGD conjugated poly(ethylene glycol)-co-poly(lactic acid) micelle enhances paclitaxel anti-glioblastoma effect
|Journal of Controlled Release|2010|365
LyP-1-conjugated PEGylated liposomes: A carrier system for targeted therapy of lymphatic metastatic tumor
|Journal of Controlled Release|2011|139
Does government debt impede firm innovation? Evidence from the rise of LGFVs in China
|Journal of Banking & Finance|2022|102
Remote‐Loaded Platelet Vesicles for Disease‐Targeted Delivery of Therapeutics
|Advanced Functional Materials|2018|87
Platelet membrane-functionalized nanoparticles with improved targeting ability and lower hemorrhagic risk for thrombolysis therapy
|Journal of Controlled Release|2020|80